Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 31 tags : Covid save search
TELUS prioritizes the health and safety of team members and customers by introducing Covid-19 vaccination policy
Published: 2021-08-31 (Crawled : 22:00) - globenewswire.com
TIXT | $8.01 2.56% 0.24% 96K
|
|
| O: -0.27%
H: 4.44%
C: 3.36%
TU | $16.07 0.94% 1.31% 1.5M
|
Communications
|
| O: 0.22%
H: 0.52%
C: 0.0%
covid vaccine
Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open
Published: 2021-08-31 (Crawled : 17:00) - biospace.com/
DGX | News | $130.09 1.29% 0.0% 1.7M
|
Health Services
|
| O: 0.05%
H: 1.35%
C: 1.32%
covid cancer diagnostics diagnostic
Study: COVID-19 Deaths Likely Due to Extremely High Viral Load
Published: 2021-08-31 (Crawled : 14:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.02%
H: 0.4%
C: 0.14%
covid covid-19
Cryogenic Control Valve Market Worth US$ 3,117.79 Million by 2028 at a CAGR of 4.7% Globally, COVID-19 Impact and Analysis by The Insight Partners
Published: 2021-08-31 (Crawled : 13:00) - prnewswire.com
FLS | $46.04 0.52% 0.0% 970K
|
Producer Manufacturing
|
| O: -0.33%
H: 0.18%
C: -0.28%
BKR | $32.46 -0.43% -0.43% 5M
|
Industrial Services
|
| O: -0.39%
H: 1.21%
C: 0.31%
covid cryo
High Virus Count in the Lungs Drives Covid-19 Deaths
Published: 2021-08-31 (Crawled : 09:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.1%
H: 0.58%
C: -0.21%
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
|
| O: -0.61%
H: 0.52%
C: 0.2%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.02%
H: 0.4%
C: 0.14%
covid lungs covid-19
Relief Reports that U.S. Collaboration Partner has Announced a New Finding from Aviptadil Phase 2b/3 Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19
Published: 2021-08-31 (Crawled : 07:00) - biospace.com/
NRXP 5 d | $3.01 -0.99% -1.0% 210K
|
Manufacturing
|
| O: -1.11%
H: 8.62%
C: 8.07%
covid phase 2 collaboration respiratory phase 2b trial aviptadil
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.